PREVENT Equations: A New Era in Cardiovascular Disease Risk Assessment.
作者信息
Razavi Alexander C, Kohli Payal, McGuire Darren K, Martin Seth S, Polonsky Tamar S, McEvoy John W, Whelton Seamus P, Blumenthal Roger S
机构信息
Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA (A.C.R.).
Department of Cardiology, University of Colorado Anschutz, Aurora (P.K.).
出版信息
Circ Cardiovasc Qual Outcomes. 2024 Apr;17(4):e010763. doi: 10.1161/CIRCOUTCOMES.123.010763. Epub 2024 Mar 20.
Abstract
摘要
相似文献
1
PREVENT Equations: A New Era in Cardiovascular Disease Risk Assessment.
Circ Cardiovasc Qual Outcomes. 2024 Apr;17(4):e010763. doi: 10.1161/CIRCOUTCOMES.123.010763. Epub 2024 Mar 20.
2
Performance of the American Heart Association PREVENT Cardiovascular Risk Equations in Older Adults.
Circ Cardiovasc Qual Outcomes. 2025 Jun;18(6):e011719. doi: 10.1161/CIRCOUTCOMES.124.011719. Epub 2025 Apr 28.
3
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.
Circulation. 2023 Dec 12;148(24):1982-2004. doi: 10.1161/CIR.0000000000001191. Epub 2023 Nov 10.
4
Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations.
JAMA Intern Med. 2024 Aug 1;184(8):963-970. doi: 10.1001/jamainternmed.2024.1302.
5
Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular disease.
Eur J Prev Cardiol. 2024 Jan 25;31(2):218-227. doi: 10.1093/eurjpc/zwad314.
6
Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, Disease.
J Am Coll Cardiol. 2023 Feb 21;81(7):633-635. doi: 10.1016/j.jacc.2022.12.007.
7
The Pooled Cohort Equations 3 Years On: Building a Stronger Foundation.
Circulation. 2016 Dec 6;134(23):1789-1791. doi: 10.1161/CIRCULATIONAHA.116.024246.
8
Reduced Risk of Cardiovascular Diseases After Bariatric Surgery Based on the New Predicting Risk of Cardiovascular Disease EVENTs Equations.
J Am Heart Assoc. 2025 Mar 18;14(6):e038191. doi: 10.1161/JAHA.124.038191. Epub 2025 Mar 7.
9
Improving prevention strategies for cardiometabolic disease.
Nat Med. 2020 Mar;26(3):320-325. doi: 10.1038/s41591-020-0786-7. Epub 2020 Mar 9.
10
Development and Validation of the American Heart Association's PREVENT Equations.
Circulation. 2024 Feb 6;149(6):430-449. doi: 10.1161/CIRCULATIONAHA.123.067626. Epub 2023 Nov 10.
引用本文的文献
1
Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort.
JACC Adv. 2025 Aug 19;4(9):102068. doi: 10.1016/j.jacadv.2025.102068.
2
Calcified Versus Noncalcified Plaque in HIV Revisited: Insights From REPRIEVE.
JACC Adv. 2025 Aug 8;4(9):102053. doi: 10.1016/j.jacadv.2025.102053.
3
LDL-C targets based on coronary artery calcium: advancing Figure 6 from the 2022 American college of cardiology expert consensus decision pathway.
Am J Prev Cardiol. 2025 Jun 26;23:101047. doi: 10.1016/j.ajpc.2025.101047. eCollection 2025 Sep.
4
Atherosclerotic Cardiovascular Disease Risk Estimates Using the New Predicting Risk of Cardiovascular Disease Events Equations: Implications for Statin Use.
Curr Cardiol Rep. 2025 Jul 2;27(1):107. doi: 10.1007/s11886-025-02244-5.
5
Cardiovascular disease risk in psoriatic disease: mechanisms and implications for clinical practice.
Curr Opin Rheumatol. 2025 Jul 1;37(4):261-268. doi: 10.1097/BOR.0000000000001092. Epub 2025 May 13.
6
Future of Stroke Prevention: 7 Updates in the 2024 AHA/ASA Primary Prevention of Stroke Guideline.
JACC Adv. 2025 Jun;4(6 Pt 2):101724. doi: 10.1016/j.jacadv.2025.101724. Epub 2025 May 8.
本文引用的文献
1
Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification.
JAMA Cardiol. 2024 Jan 1;9(1):55-62. doi: 10.1001/jamacardio.2023.4520.
2
Development and Validation of the American Heart Association's PREVENT Equations.
Circulation. 2024 Feb 6;149(6):430-449. doi: 10.1161/CIRCULATIONAHA.123.067626. Epub 2023 Nov 10.
3
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
Eur Heart J. 2023 Oct 14;44(39):4043-4140. doi: 10.1093/eurheartj/ehad192.
4
Coronary Artery Calcium Score and Polygenic Risk Score for the Prediction of Coronary Heart Disease Events.
JAMA. 2023 May 23;329(20):1768-1777. doi: 10.1001/jama.2023.7575.
5
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
6
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis.
JAMA Cardiol. 2021 Feb 1;6(2):148-158. doi: 10.1001/jamacardio.2020.4511.
7
10-Year Risk Equations for Incident Heart Failure in the General Population.
J Am Coll Cardiol. 2019 May 21;73(19):2388-2397. doi: 10.1016/j.jacc.2019.02.057.
8
10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study).
J Am Coll Cardiol. 2015 Oct 13;66(15):1643-53. doi: 10.1016/j.jacc.2015.08.035.
9
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.
10
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study.
Ann Intern Med. 1961 Jul;55:33-50. doi: 10.7326/0003-4819-55-1-33.
Zotero 插件